_id

6919eebf3c536f8df23184f2

Ticker

STX.LSE

Name

Shield Therapeutics plc

Exchange

LSE

Address

Northern Design Centre, Gateshead, United Kingdom, NE8 3DF

Country

UK

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Currency

GBX

Website

https://www.shieldtherapeutics.com

Description

Shield Therapeutics plc, a commercial stage specialty pharmaceutical company, focuses on development and commercialization of clinical-stage pharmaceuticals to treat unmet medical needs. Its lead product is Accrufer/Feraccru, a non-salt based oral therapy for adults to treat the iron deficiency with or without anemia. Shield Therapeutics plc was incorporated in 2008 and is based in Gateshead, the United Kingdom.

Last Close

103000

Volume

1081281

Current Price

11.55

Change

-2.9126213592233077

Last Updated

2025-12-30T11:35:27.798Z

Image

https://logo.clearbit.com/www.shieldtherapeutics.com

Ipo Date

-

Market Cap

109365688

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

-

Sentiment Sources

0

Rating

4

Strong Buy

0

Buy

2

Hold

0

Sell

0

Strong Sell

0

Current Quarter

2025-06-30

Revenue

16539751

Cost Of Revenue

8921147

Gross Profit

7618604

Operating Expenses

12084576

Operating Income

-4465972

Interest Expense

2895825

Pretax Income

-7231466

Net Income

-7353314

Eps

-0.007059020038048077

Dividends Per Share

-

Shares Outstanding

1061802812

Income Tax Expense

121848

EBITDA

-3789637

Operating Margin

-27.001446394205086

Total Other Income Expense Net

-2765494

Cash

10814000

Short Term Investments

-

Receivables

23693000

Inventories

6748000

Total Current Assets

41363000

Property Plant Equipment

228000

Total Assets

62099000

Payables

16098000

Short Term Debt

99000

Long Term Debt

26949000

Total Liabilities

76956000

Equity

-14857000

Bs_currency_symbol

USD

Depreciation

546003

Change In Working Capital

1756775

Cash From Operations

-4494506

Capital Expenditures

3.8

Cash From Investing

-1011803

Cash From Financing

7575417

Net Change In Cash

2282983

Cf_currency_symbol

-

PE

-

PB

-809.8219755132261

ROE

49.493935518610755

ROA

-11.841276026989163

FCF

-4494509.8

Fcf Percent

-0.2717398708118399

Piotroski FScore

1

Health Score

31

Deep Value Investing Score

0.5

Defensive Investing Score

7

Dividend Investing Score

1.5

Economic Moat Investing Score

5.3

Garp Investing Score

3

Growth Investing Score

3

Momentum Investing Score

2

Net Net Investing Score

0.5

Quality Investing Score

2.5

Value Investing Score

2.5

Quarters > 0 > quarter

2025-06-30

Quarters > 0 > income Statement > revenue

16539751

Quarters > 0 > income Statement > cost Of Revenue

8921147

Quarters > 0 > income Statement > gross Profit

7618604

Quarters > 0 > income Statement > operating Expenses

12084576

Quarters > 0 > income Statement > operating Income

-4465972

Quarters > 0 > income Statement > interest Expense

2895825

Quarters > 0 > income Statement > pretax Income

-7231466

Quarters > 0 > income Statement > net Income

-7353314

Quarters > 0 > income Statement > eps

-0.007059020038048077

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

1041690484

Quarters > 0 > income Statement > income Tax Expense

121848

Quarters > 0 > income Statement > EBITDA

-3789637

Quarters > 0 > income Statement > operating Margin

-27.001446394205086

Quarters > 0 > income Statement > total Other Income Expense Net

-2765494

Quarters > 0 > income Statement > currency_symbol

-

Quarters > 0 > balance Sheet > cash

10814000

Quarters > 0 > balance Sheet > short Term Investments

-

Quarters > 0 > balance Sheet > receivables

23693000

Quarters > 0 > balance Sheet > inventories

6748000

Quarters > 0 > balance Sheet > total Current Assets

41363000

Quarters > 0 > balance Sheet > property Plant Equipment

228000

Quarters > 0 > balance Sheet > total Assets

62099000

Quarters > 0 > balance Sheet > payables

16098000

Quarters > 0 > balance Sheet > short Term Debt

99000

Quarters > 0 > balance Sheet > long Term Debt

26949000

Quarters > 0 > balance Sheet > total Liabilities

76956000

Quarters > 0 > balance Sheet > equity

-14857000

Quarters > 0 > balance Sheet > currency_symbol

USD

Quarters > 0 > cash Flow > net Income

-7353314

Quarters > 0 > cash Flow > depreciation

546003

Quarters > 0 > cash Flow > change In Working Capital

1756775

Quarters > 0 > cash Flow > cash From Operations

-4494506

Quarters > 0 > cash Flow > capital Expenditures

3.8

Quarters > 0 > cash Flow > cash From Investing

-1011803

Quarters > 0 > cash Flow > cash From Financing

7575417

Quarters > 0 > cash Flow > net Change In Cash

2282983

Quarters > 0 > cash Flow > currency_symbol

-

Quarters > 0 > ratios > PE

-0.007059020038048077

Quarters > 0 > ratios > PB

-809.8219755132261

Quarters > 0 > ratios > ROE

49.493935518610755

Quarters > 0 > ratios > ROA

-11.841276026989163

Quarters > 0 > ratios > FCF

-4494509.8

Quarters > 0 > ratios > Piotroski FScore

1

Quarters > 0 > ratios > fcf Percent

-0.2717398708118399

Quarters > 0 > health Score

31

Quarters > 1 > quarter

2024-12-31

Quarters > 1 > income Statement > revenue

15531399

Quarters > 1 > income Statement > cost Of Revenue

8830926

Quarters > 1 > income Statement > gross Profit

6700473

Quarters > 1 > income Statement > operating Expenses

14202770

Quarters > 1 > income Statement > operating Income

-6863936

Quarters > 1 > income Statement > interest Expense

1800427

Quarters > 1 > income Statement > pretax Income

-8580695

Quarters > 1 > income Statement > net Income

-9067213

Quarters > 1 > income Statement > eps

-0.011594065827738476

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

782056367

Quarters > 1 > income Statement > income Tax Expense

486518

Quarters > 1 > income Statement > EBITDA

-6141908

Quarters > 1 > income Statement > operating Margin

-44.19393256203127

Quarters > 1 > income Statement > total Other Income Expense Net

-1716759

Quarters > 1 > income Statement > currency_symbol

-

Quarters > 1 > balance Sheet > cash

5608431

Quarters > 1 > balance Sheet > short Term Investments

-

Quarters > 1 > balance Sheet > receivables

20164484

Quarters > 1 > balance Sheet > inventories

4520121

Quarters > 1 > balance Sheet > total Current Assets

30293037

Quarters > 1 > balance Sheet > property Plant Equipment

297828

Quarters > 1 > balance Sheet > total Assets

45895879

Quarters > 1 > balance Sheet > payables

18514851

Quarters > 1 > balance Sheet > short Term Debt

156499

Quarters > 1 > balance Sheet > long Term Debt

26174000

Quarters > 1 > balance Sheet > total Liabilities

46947460

Quarters > 1 > balance Sheet > equity

-1051580

Quarters > 1 > balance Sheet > currency_symbol

USD

Quarters > 1 > cash Flow > net Income

-9067213

Quarters > 1 > cash Flow > depreciation

638361

Quarters > 1 > cash Flow > change In Working Capital

5250581

Quarters > 1 > cash Flow > cash From Operations

-3659534

Quarters > 1 > cash Flow > capital Expenditures

235

Quarters > 1 > cash Flow > cash From Investing

-284788

Quarters > 1 > cash Flow > cash From Financing

4257350

Quarters > 1 > cash Flow > net Change In Cash

-798498

Quarters > 1 > cash Flow > currency_symbol

-

Quarters > 1 > ratios > PE

-0.011594065827738476

Quarters > 1 > ratios > PB

-8589.694591804713

Quarters > 1 > ratios > ROE

862.2466193727535

Quarters > 1 > ratios > ROA

-19.756050428841334

Quarters > 1 > ratios > FCF

-3659769

Quarters > 1 > ratios > Piotroski FScore

1

Quarters > 1 > ratios > fcf Percent

-0.2356367897058082

Quarters > 1 > health Score

31

Quarters > 2 > quarter

2024-06-30

Quarters > 2 > income Statement > revenue

9592154

Quarters > 2 > income Statement > cost Of Revenue

5277582

Quarters > 2 > income Statement > gross Profit

4314572

Quarters > 2 > income Statement > operating Expenses

15470630

Quarters > 2 > income Statement > operating Income

-11156058

Quarters > 2 > income Statement > interest Expense

1284804

Quarters > 2 > income Statement > pretax Income

-12239247

Quarters > 2 > income Statement > net Income

-12237666

Quarters > 2 > income Statement > eps

-0.015648061337246295

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

782056367

Quarters > 2 > income Statement > income Tax Expense

-1581

Quarters > 2 > income Statement > EBITDA

-10479266

Quarters > 2 > income Statement > operating Margin

-116.30399178328454

Quarters > 2 > income Statement > total Other Income Expense Net

-1083189

Quarters > 2 > income Statement > currency_symbol

-

Quarters > 2 > balance Sheet > cash

6406929

Quarters > 2 > balance Sheet > short Term Investments

-

Quarters > 2 > balance Sheet > receivables

12421485

Quarters > 2 > balance Sheet > inventories

3191994

Quarters > 2 > balance Sheet > total Current Assets

22020409

Quarters > 2 > balance Sheet > property Plant Equipment

414524

Quarters > 2 > balance Sheet > total Assets

36991535

Quarters > 2 > balance Sheet > payables

-

Quarters > 2 > balance Sheet > short Term Debt

230994

Quarters > 2 > balance Sheet > long Term Debt

19679000

Quarters > 2 > balance Sheet > total Liabilities

36563563

Quarters > 2 > balance Sheet > equity

427972

Quarters > 2 > balance Sheet > currency_symbol

USD

Quarters > 2 > cash Flow > net Income

-12237666

Quarters > 2 > cash Flow > depreciation

475180

Quarters > 2 > cash Flow > change In Working Capital

7206766

Quarters > 2 > cash Flow > cash From Operations

-3276449

Quarters > 2 > cash Flow > capital Expenditures

800136

Quarters > 2 > cash Flow > cash From Investing

-1590785

Quarters > 2 > cash Flow > cash From Financing

-92505

Quarters > 2 > cash Flow > net Change In Cash

-4534395

Quarters > 2 > cash Flow > currency_symbol

-

Quarters > 2 > ratios > PE

-0.015648061337246295

Quarters > 2 > ratios > PB

21105.939264367764

Quarters > 2 > ratios > ROE

-2859.454824147374

Quarters > 2 > ratios > ROA

-33.0823416762781

Quarters > 2 > ratios > FCF

-4076585

Quarters > 2 > ratios > Piotroski FScore

1

Quarters > 2 > ratios > fcf Percent

-0.42499161293698995

Quarters > 2 > health Score

9

Quarters > 3 > quarter

2023-12-31

Quarters > 3 > income Statement > revenue

6983988

Quarters > 3 > income Statement > cost Of Revenue

6001553

Quarters > 3 > income Statement > gross Profit

982435

Quarters > 3 > income Statement > operating Expenses

16844253

Quarters > 3 > income Statement > operating Income

-15861820

Quarters > 3 > income Statement > interest Expense

785309

Quarters > 3 > income Statement > pretax Income

-16426060

Quarters > 3 > income Statement > net Income

-16510656

Quarters > 3 > income Statement > eps

-0.022245861571834707

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

742190000

Quarters > 3 > income Statement > income Tax Expense

84596

Quarters > 3 > income Statement > EBITDA

-15637562

Quarters > 3 > income Statement > operating Margin

-227.11694235442556

Quarters > 3 > income Statement > total Other Income Expense Net

-564240

Quarters > 3 > income Statement > currency_symbol

-

Quarters > 3 > balance Sheet > cash

10941324

Quarters > 3 > balance Sheet > short Term Investments

-

Quarters > 3 > balance Sheet > receivables

8796673

Quarters > 3 > balance Sheet > inventories

2512550

Quarters > 3 > balance Sheet > total Current Assets

24523846

Quarters > 3 > balance Sheet > property Plant Equipment

527925

Quarters > 3 > balance Sheet > total Assets

38279730

Quarters > 3 > balance Sheet > payables

4049000

Quarters > 3 > balance Sheet > short Term Debt

381869

Quarters > 3 > balance Sheet > long Term Debt

19836000

Quarters > 3 > balance Sheet > total Liabilities

26487292

Quarters > 3 > balance Sheet > equity

11792438

Quarters > 3 > balance Sheet > currency_symbol

USD

Quarters > 3 > cash Flow > net Income

-16510656

Quarters > 3 > cash Flow > depreciation

436549

Quarters > 3 > cash Flow > change In Working Capital

1737934

Quarters > 3 > cash Flow > cash From Operations

-13835700

Quarters > 3 > cash Flow > capital Expenditures

1019593

Quarters > 3 > cash Flow > cash From Investing

-1019593

Quarters > 3 > cash Flow > cash From Financing

15685778

Quarters > 3 > cash Flow > net Change In Cash

248754

Quarters > 3 > cash Flow > currency_symbol

USD

Quarters > 3 > ratios > PE

-0.022245861571834707

Quarters > 3 > ratios > PB

726.931487789039

Quarters > 3 > ratios > ROE

-140.0105389572538

Quarters > 3 > ratios > ROA

-43.13158948613274

Quarters > 3 > ratios > FCF

-14855293

Quarters > 3 > ratios > Piotroski FScore

1

Quarters > 3 > ratios > fcf Percent

-2.1270501896624108

Quarters > 3 > health Score

13

Annuals > 0 > quarter

2024-12-31

Annuals > 0 > income Statement > revenue

25183667

Annuals > 0 > income Statement > cost Of Revenue

14614822

Annuals > 0 > income Statement > gross Profit

10568845

Annuals > 0 > income Statement > operating Expenses

37803000

Annuals > 0 > income Statement > operating Income

-17976035

Annuals > 0 > income Statement > interest Expense

3090438

Annuals > 0 > income Statement > pretax Income

-20782394

Annuals > 0 > income Statement > net Income

-21272294

Annuals > 0 > income Statement > eps

-0.0235

Annuals > 0 > income Statement > dividends Per Share

-

Annuals > 0 > income Statement > shares Outstanding

905204000

Annuals > 0 > income Statement > income Tax Expense

489899

Annuals > 0 > income Statement > EBITDA

-16576770

Annuals > 0 > income Statement > operating Margin

-71.37973592169877

Annuals > 0 > income Statement > total Other Income Expense Net

-2806359

Annuals > 0 > income Statement > currency_symbol

USD

Annuals > 0 > balance Sheet > cash

5608431

Annuals > 0 > balance Sheet > short Term Investments

-

Annuals > 0 > balance Sheet > receivables

20164484

Annuals > 0 > balance Sheet > inventories

4520121

Annuals > 0 > balance Sheet > total Current Assets

30293037

Annuals > 0 > balance Sheet > property Plant Equipment

297828

Annuals > 0 > balance Sheet > total Assets

45895879

Annuals > 0 > balance Sheet > payables

18514851

Annuals > 0 > balance Sheet > short Term Debt

352499

Annuals > 0 > balance Sheet > long Term Debt

26174000

Annuals > 0 > balance Sheet > total Liabilities

46947460

Annuals > 0 > balance Sheet > equity

-1051580

Annuals > 0 > balance Sheet > currency_symbol

USD

Annuals > 0 > cash Flow > net Income

-21272294

Annuals > 0 > cash Flow > depreciation

1115187

Annuals > 0 > cash Flow > change In Working Capital

12584007

Annuals > 0 > cash Flow > cash From Operations

-7006506

Annuals > 0 > cash Flow > capital Expenditures

27393

Annuals > 0 > cash Flow > cash From Investing

-1894644

Annuals > 0 > cash Flow > cash From Financing

4207190

Annuals > 0 > cash Flow > net Change In Cash

-5332893

Annuals > 0 > cash Flow > currency_symbol

USD

Annuals > 0 > ratios > PE

-0.0235

Annuals > 0 > ratios > PB

-8762.982103121018

Annuals > 0 > ratios > ROE

2022.8887959071112

Annuals > 0 > ratios > ROA

-46.34902841712651

Annuals > 0 > ratios > FCF

-7033899

Annuals > 0 > ratios > Piotroski FScore

1

Annuals > 0 > ratios > fcf Percent

-0.27930400286820817

Annuals > 0 > health Score

31

Annuals > 1 > quarter

2023-12-31

Annuals > 1 > income Statement > revenue

13085000

Annuals > 1 > income Statement > cost Of Revenue

9058000

Annuals > 1 > income Statement > gross Profit

4027000

Annuals > 1 > income Statement > operating Expenses

35358000

Annuals > 1 > income Statement > operating Income

-31331000

Annuals > 1 > income Statement > interest Expense

819756

Annuals > 1 > income Statement > pretax Income

-32375000

Annuals > 1 > income Statement > net Income

-33293000

Annuals > 1 > income Statement > eps

-0.04607747071458624

Annuals > 1 > income Statement > dividends Per Share

-

Annuals > 1 > income Statement > shares Outstanding

722544000

Annuals > 1 > income Statement > income Tax Expense

918000

Annuals > 1 > income Statement > EBITDA

-30288000

Annuals > 1 > income Statement > operating Margin

-239.44210928544135

Annuals > 1 > income Statement > total Other Income Expense Net

-1044000

Annuals > 1 > income Statement > currency_symbol

USD

Annuals > 1 > balance Sheet > cash

13948000

Annuals > 1 > balance Sheet > short Term Investments

-3006676

Annuals > 1 > balance Sheet > receivables

10600000

Annuals > 1 > balance Sheet > inventories

3203000

Annuals > 1 > balance Sheet > total Current Assets

31263000

Annuals > 1 > balance Sheet > property Plant Equipment

673000

Annuals > 1 > balance Sheet > total Assets

48799000

Annuals > 1 > balance Sheet > payables

4049000

Annuals > 1 > balance Sheet > short Term Debt

381869

Annuals > 1 > balance Sheet > long Term Debt

19836000

Annuals > 1 > balance Sheet > total Liabilities

26487292

Annuals > 1 > balance Sheet > equity

11792438

Annuals > 1 > balance Sheet > currency_symbol

USD

Annuals > 1 > cash Flow > net Income

-33293000

Annuals > 1 > cash Flow > depreciation

1071000

Annuals > 1 > cash Flow > change In Working Capital

-7024000

Annuals > 1 > cash Flow > cash From Operations

-37126000

Annuals > 1 > cash Flow > capital Expenditures

2948000

Annuals > 1 > cash Flow > cash From Investing

-2430000

Annuals > 1 > cash Flow > cash From Financing

49656000

Annuals > 1 > cash Flow > net Change In Cash

10546000

Annuals > 1 > cash Flow > currency_symbol

USD

Annuals > 1 > ratios > PE

-0.04607747071458624

Annuals > 1 > ratios > PB

623.7470080402372

Annuals > 1 > ratios > ROE

-282.3249950519138

Annuals > 1 > ratios > ROA

-68.2247587040718

Annuals > 1 > ratios > FCF

-40074000

Annuals > 1 > ratios > Piotroski FScore

1

Annuals > 1 > ratios > fcf Percent

-3.0625907527703475

Annuals > 1 > health Score

13

Annuals > 2 > quarter

2022-12-31

Annuals > 2 > income Statement > revenue

5499000

Annuals > 2 > income Statement > cost Of Revenue

2470000

Annuals > 2 > income Statement > gross Profit

1997000

Annuals > 2 > income Statement > operating Expenses

27703000

Annuals > 2 > income Statement > operating Income

-26391072

Annuals > 2 > income Statement > interest Expense

333663

Annuals > 2 > income Statement > pretax Income

-40082000

Annuals > 2 > income Statement > net Income

-40444000

Annuals > 2 > income Statement > eps

-0.17343796903812342

Annuals > 2 > income Statement > dividends Per Share

7529000

Annuals > 2 > income Statement > shares Outstanding

233190000

Annuals > 2 > income Statement > income Tax Expense

446000

Annuals > 2 > income Statement > EBITDA

-46067000

Annuals > 2 > income Statement > operating Margin

-479.9249318057829

Annuals > 2 > income Statement > total Other Income Expense Net

-13667211

Annuals > 2 > income Statement > currency_symbol

GBP

Annuals > 2 > balance Sheet > cash

2821000

Annuals > 2 > balance Sheet > short Term Investments

-

Annuals > 2 > balance Sheet > receivables

3753429

Annuals > 2 > balance Sheet > inventories

1457000

Annuals > 2 > balance Sheet > total Current Assets

10094000

Annuals > 2 > balance Sheet > property Plant Equipment

197000

Annuals > 2 > balance Sheet > total Assets

22074000

Annuals > 2 > balance Sheet > payables

1735000

Annuals > 2 > balance Sheet > short Term Debt

195951

Annuals > 2 > balance Sheet > long Term Debt

6008000

Annuals > 2 > balance Sheet > total Liabilities

16647000

Annuals > 2 > balance Sheet > equity

5427000

Annuals > 2 > balance Sheet > currency_symbol

GBP

Annuals > 2 > cash Flow > net Income

-28662000

Annuals > 2 > cash Flow > depreciation

2332396

Annuals > 2 > cash Flow > change In Working Capital

3186445

Annuals > 2 > cash Flow > cash From Operations

-18247000

Annuals > 2 > cash Flow > capital Expenditures

1895000

Annuals > 2 > cash Flow > cash From Investing

-1695000

Annuals > 2 > cash Flow > cash From Financing

7707000

Annuals > 2 > cash Flow > net Change In Cash

-9296000

Annuals > 2 > cash Flow > currency_symbol

GBP

Annuals > 2 > ratios > PE

-0.17343796903812342

Annuals > 2 > ratios > PB

437.4192371475953

Annuals > 2 > ratios > ROE

-745.2367790676249

Annuals > 2 > ratios > ROA

-183.22007791972456

Annuals > 2 > ratios > FCF

-20142000

Annuals > 2 > ratios > Piotroski FScore

0

Annuals > 2 > ratios > fcf Percent

-3.662847790507365

Annuals > 2 > health Score

8

Annuals > 3 > quarter

2021-12-31

Annuals > 3 > income Statement > revenue

1519000

Annuals > 3 > income Statement > cost Of Revenue

980000

Annuals > 3 > income Statement > gross Profit

539000

Annuals > 3 > income Statement > operating Expenses

20491000

Annuals > 3 > income Statement > operating Income

-20405000

Annuals > 3 > income Statement > interest Expense

8000

Annuals > 3 > income Statement > pretax Income

-19907000

Annuals > 3 > income Statement > net Income

-19336000

Annuals > 3 > income Statement > eps

-0.09459419793552175

Annuals > 3 > income Statement > dividends Per Share

-

Annuals > 3 > income Statement > shares Outstanding

204410000

Annuals > 3 > income Statement > income Tax Expense

-229000

Annuals > 3 > income Statement > EBITDA

-17692000

Annuals > 3 > income Statement > operating Margin

-1343.3179723502303

Annuals > 3 > income Statement > total Other Income Expense Net

498000

Annuals > 3 > income Statement > currency_symbol

GBP

Annuals > 3 > balance Sheet > cash

12117000

Annuals > 3 > balance Sheet > short Term Investments

-

Annuals > 3 > balance Sheet > receivables

1773000

Annuals > 3 > balance Sheet > inventories

1635000

Annuals > 3 > balance Sheet > total Current Assets

17258000

Annuals > 3 > balance Sheet > property Plant Equipment

304000

Annuals > 3 > balance Sheet > total Assets

44413000

Annuals > 3 > balance Sheet > payables

4200000

Annuals > 3 > balance Sheet > short Term Debt

366000

Annuals > 3 > balance Sheet > long Term Debt

0

Annuals > 3 > balance Sheet > total Liabilities

3380000

Annuals > 3 > balance Sheet > equity

40691000

Annuals > 3 > balance Sheet > currency_symbol

GBP

Annuals > 3 > cash Flow > net Income

-19678000

Annuals > 3 > cash Flow > depreciation

2207000

Annuals > 3 > cash Flow > change In Working Capital

-1793000

Annuals > 3 > cash Flow > cash From Operations

-16738000

Annuals > 3 > cash Flow > capital Expenditures

2064000

Annuals > 3 > cash Flow > cash From Investing

-2051000

Annuals > 3 > cash Flow > cash From Financing

27584000

Annuals > 3 > cash Flow > net Change In Cash

9177000

Annuals > 3 > cash Flow > currency_symbol

GBP

Annuals > 3 > ratios > PE

-0.09459419793552175

Annuals > 3 > ratios > PB

51.13892015433388

Annuals > 3 > ratios > ROE

-47.51910741933106

Annuals > 3 > ratios > ROA

-43.53680228761849

Annuals > 3 > ratios > FCF

-18802000

Annuals > 3 > ratios > Piotroski FScore

0

Annuals > 3 > ratios > fcf Percent

-12.377880184331797

Annuals > 3 > health Score

26

Valuation > metrics > PE

-0.007059020038048077

Valuation > metrics > PB

-809.8219755132261

Valuation > final Score

50

Valuation > verdict

Fair

Profitability > metrics > ROE

49.493935518610755

Profitability > metrics > ROA

-17.777516137610906

Profitability > metrics > Net Margin

-0.4445843229441604

Profitability > final Score

40

Profitability > verdict

Weak

Risk > metrics > Interest Coverage

-1.5422105962894856

Risk > final Score

24

Risk > verdict

High

Liquidity > metrics > Current Ratio

2.5537445205902327

Liquidity > metrics > Quick Ratio

2.1371241587948386

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

50

Prev Valuations > 1

20

Prev Valuations > 2

20

Prev Profitabilities > 0

40

Prev Profitabilities > 1

0

Prev Profitabilities > 2

0

Prev Risks > 0

15

Prev Risks > 1

-29

Prev Risks > 2

-63

Prev Liquidities > 0

91

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2026-01-20T23:04:10.272Z

Earnings History > 0 > period

2026-03-31

Earnings History > 0 > report Date

2026-04-22

Earnings History > 0 > date

2026-03-31

Earnings History > 0 > before After Market

BeforeMarket

Earnings History > 0 > currency

-

Earnings History > 0 > eps Actual

-

Earnings History > 0 > eps Estimate

-

Earnings History > 0 > eps Difference

0

Earnings History > 0 > surprise Percent

-